Hae
Aineistot 1-1 / 1
CIP2A is a critical DNA damage response protein that drives basal-like breast cancer
(Turun yliopisto, 2023-04-14)
Basal-like breast cancer (BLBC) is an aggressive and therapeutically most challenging breast cancer subtype, due to a lack of druggable breast specific surface receptors (ER, PR, HER2) or driver mechanisms. BLBC patients ...